Mycobacterium avium-intracellulare: a cause of disseminated life-threatening infection in homosexuals and drug abusers.
- J. B. Greene, G. S. Sidhu, R. Holzman
- Medicine, BiologyAnnals of Internal Medicine
- 1 October 1982
The spectrum of opportunistic infections among populations of homosexuals and drug abusers should be expanded to include disseminated disease due to M. avium-intracellulare, as well as commonly used antimycobacterial drugs.
Rickettsialpox: Report of an Outbreak and a Contemporary Review
- L. Brettman, S. Lewin, R. Schinella
- MedicineMedicine
- 1 September 1981
There is no convincing evidence of cross-immunity to these agents after recovery from rickettsialpox, and Tetracyclinie is the drug of choice in the treatment of this disease.
Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study
- D. Selvig, Y. Piceno, Najwa El-Nachef
- MedicineDigestive Diseases and Sciences
- 13 July 2019
A single FMT has a tolerable short-term safety profile and may be associated with a decrease in bowel movements in patients with chronic pouchitis; however, no robust endoscopic or histologic changes were observed.
Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia.
- R. Berkelman, S. Lewin, R. Haley
- Medicine, BiologyAnnals of Internal Medicine
- 1 July 1981
E Epidemiologic investigation in one hospital indicated that the positive results of blood culture represented pseudobacteremias and implicated a 10% povidone-iodine solution used as an antiseptic and disinfectant (Pharmadine; Sherwood Pharmaceutical Company, Mahwah, New Jersey) as the source of contamination.
Legionnaires' disease. A cause of severe abscess-forming pneumonia.
- S. Lewin, L. Brettman, P. Edelstein
- MedicineAmerican Journal of Medicine
- 1979
Infections in hypothermic patients.
- S. Lewin, L. Brettman, R. Holzman
- MedicineArchives of Internal Medicine
- 1 June 1981
Since infection is frequently masked in hypothermic patients, careful repeated evaluations should be carried out to identify early infections and it is believed that prompt empiric antibiotic therapy is appropriate.
Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics
- E. Mao, S. Lewin, J. Terdiman, Kendall R. Beck
- MedicineBMJ Open Gastroenterology
- 1 November 2018
The efficacy of DBT remains unproven but it appears promising as three of the four patients achieved clinical remission, and the case series contributes insight into the safety of D BT that incorporates vedolizumab for future efficacy studies.
International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases
- S. Lewin, C. Lees, M. Regueiro, A. Hart, U. Mahadevan
- MedicineJournal of Crohn's & Colitis
- 1 October 2020
Insight is provided into past and current practices among inflammatory bowel disease specialists and regulatory, financial and practical considerations for incorporating telemedicine into clinical practice to sustain the use of telemedics long after the current pandemic subsides.
Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol.
- S. Lewin, R. McConnell, Roshan Patel, S. Sharpton, F. Velayos, U. Mahadevan
- MedicineInflammatory Bowel Diseases
- 18 October 2019
Evidence-based inpatient ulcerative colitis management may be optimized with standardized algorithms that reinforce core principles, reduce care variation, and do not require IBD specialists to implement.
Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience.
- Prashant Kotwani, J. Terdiman, S. Lewin
- MedicineJournal of Crohn's & Colitis
- 5 February 2020
Tofacitinib may be an acceptable rescue agent in biologic-experienced patients with acute-severe ulcerative colitis and may also be safely continued as maintenance therapy once remission has been achieved.
...
...